Multiples.
MarketsValue ChainSectorsComp AnalysisRegressionAdvisor Insights
Market data via Financial Modeling Prep. Not investment advice.
Multiples.
⌘K
Sectors

Pharma & Biotech

· 3 companies

Drug developers, pharmaceutical manufacturers, life-sciences research/services businesses, and therapeutic platforms.

Companies
3
Aggregate Market Cap
$413.71B
Median EV / NTM Rev
1.9x
Median NTM Growth
6.2%
Pharma & Biotech multiples over time →

Subsectors

Large-Cap & Specialty Pharmaceuticals
Branded pharmaceuticals; specialty pharma; rare-disease franchises; established-product portfolios.
2
Biotechnology
Clinical-stage biotech; commercial-stage biotech; platform biotech; biologics; cell/gene therapy.
1
Generic, Biosimilar & Contract Pharma
Generics; biosimilars; CDMOs; active pharmaceutical ingredients; drug delivery/manufacturing.
0
Life-Sciences Tools & Services
CROs; clinical research; bioinformatics/data; drug discovery services; laboratory services.
0
Animal Health
Veterinary pharmaceuticals; animal vaccines; companion-animal diagnostics; livestock health.
0
Open comp table →·Open regression →

Market data via Financial Modeling Prep. Informational only — not investment advice.

© 2026 Flashpoint Capital. All rights reserved.

Terms & ConditionsDisclaimerWebsite by Flashpoint Capital